World
Breakthrough in Addiction Treatment: Brazilian Scientists Pioneering New ‘Vaccine’ for Cocaine Addiction
In a significant leap forward in the battle against cocaine addiction, scientists in Brazil, the...
Trial Commences in Gambia Over Tragic Deaths Linked to Maiden Pharmaceuticals’ Cough Syrup
A trial officially commenced in Banjul, The Gambia, on Tuesday, centered on the tragic deaths...
Zydus Advances Phase II Trial of ZYIL1, a Promising NLRP3 Inhibitor, in ALS Patients
Zydus Life Sciences has received the green light from the Central Drugs Standard Control Organization...
UK Online Pharmacy, ‘Rightangled’ Continues Sales of Ozempic, Defying Government Order
Rightangled, a prominent UK-based online pharmacy, is at the center of controversy for continuing the...
Pfizer India Collaborates with KIMS Hospital to Launch Center of Excellence for Adult Vaccination
Pfizer India, a leading pharmaceutical company, has joined forces with Krishna Institute of Medical Sciences...
Merck Ends Collaboration with Sichuan Kelun on Promising Cancer Drug Development
Sichuan Kelun Pharmaceutical Co, a prominent Chinese pharmaceutical company, announced on Monday a significant setback...
Lupin Receives USFDA Green Light for Generic Antifungal Tablets
Lupin Ltd, a prominent player in the pharmaceutical industry, announced on Monday that it has...
Mylan Laboratories Faces FIR for Inflated Pricing of BMC Remdesivir Vials During COVID-19 Crisis
In a significant development, the City's Economic Offences Wing (EOW) has recently registered a First...
ADHD in Adults Linked to Higher Dementia Risk: Rutgers Study
A study conducted by Rutgers University has unveiled a concerning connection between adult Attention-Deficit/Hyperactivity Disorder...
WhatsApp Unveils Dual-Account Feature: Seamlessly Manage Work and Personal Life on a Single Device
Introduction In a groundbreaking move, WhatsApp, owned by Meta, has introduced a dual-account feature that...
